Literature DB >> 3260777

High affinity binding sites for epidermal growth factor (EGF) in renal membranes.

E Sack1, Z Talor.   

Abstract

The kidney produces large quantities of EGF but the role of the kidney in binding and degradation of EGF is unknown. We studied 125I-EGF binding and degradation by highly purified cortical luminal and cortical basolateral membranes of rabbit renal cortex, and by medullary plasma membranes. Specific binding for 125I-EGF was found for the first time in cortical basolateral and medullary plasma membranes (60-80% of total binding) but not in cortical luminal membranes. There was little degradation (less than 4%) of EGF by any of the membranes. Scatchard analysis of 125I-EGF binding by cortical basolateral membranes revealed two distinct classes of binding sites: high and low affinity. The existence of high specific binding sites in cortical basolateral and in medullary plasma membranes suggests a physiologic role of EGF in the kidney.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260777     DOI: 10.1016/0006-291x(88)90686-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia.

Authors:  Wouter M Tiel Groenestege; Stéphanie Thébault; Jenny van der Wijst; Dennis van den Berg; Rob Janssen; Sabine Tejpar; Lambertus P van den Heuvel; Eric van Cutsem; Joost G Hoenderop; Nine V Knoers; René J Bindels
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  Peptide-dependent regulation of epithelial nephron functions.

Authors:  M Horster; M Sone
Journal:  Klin Wochenschr       Date:  1989-09-01

3.  Localization of epidermal growth factor (EGF) binding sites on antiluminal plasma membrane of rat kidney: autoradiographic study using nonfiltering perfused rat kidney.

Authors:  D C Kim; Y Sugiyama; Y Kanai; N Ohnuma; M Hanano
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

4.  Electrolyte and protein imbalance following anti-EGFR therapy in cancer patients: A comparative study.

Authors:  Pius Maliakal; Andrea Ledford
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

5.  Growth factor binding and bioactivity in human kidney epithelial cell cultures.

Authors:  T Gansler; W C Hsu; T S Gramling; K A Robinson; M G Buse; N Blocker; L Roy; S Green; A J Garvin; D A Sens
Journal:  In Vitro Cell Dev Biol       Date:  1990-03

6.  Autosomal recessive polycystic kidney disease epithelial cell model reveals multiple basolateral epidermal growth factor receptor sorting pathways.

Authors:  Sean Ryan; Susamma Verghese; Nicholas L Cianciola; Calvin U Cotton; Cathleen R Carlin
Journal:  Mol Biol Cell       Date:  2010-06-02       Impact factor: 4.138

7.  Localization of binding sites for epidermal growth factor (EGF) in rat kidney: evidence for the existence of low affinity EGF binding sites on the brush border membrane.

Authors:  D C Kim; M Hanano; Y Kanai; N Ohnuma; Y Sugiyama
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

Review 8.  Role of epidermal growth factor receptor in acute and chronic kidney injury.

Authors:  Jinhua Tang; Na Liu; Shougang Zhuang
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.